Hetero launches generic drug, ‘Covifor’ for COVID-19 treatment
DCGI approved to produce Covifor, the generic version of Gilead’s Remdesivir drug
The drug will be available in a 100-milligram vial
It has to be administered intravenously under the supervision of a healthcare practitioner
Each 100 mg vial is likely to be priced between Rs 5,000 and Rs 6,000
